Description: Over the past month, the evolution of the COVID-19 pandemic has raised questions on how this outbreak will impact life insurance industry claims. This report pulls emerging U.S. COVID-19 hospitalization data and deaths obtained from the Centers for Disease Control and Prevention’s (CDC) COVIDView, a Weekly Surveillance Summary of U.S. COVID-19 activity, and compares it to data from past U.S. influenza seasons obtained from the CDC’s Flu Activity and Surveillance webpage.

Description: Using recently updated data from the United States Mortality Database (USMDB, usa.mortality.org), this report presents an overview of historical mortality trends in all 50 U.S. states and the District of Columbia for the period 1959-2018.

Description: This report summarizes industry mortality experience for the period 2009 - 2016. This report is updated on a mostly annual basis and based on information aggregated from industry VM-51 submissions

Description: This report models and forecasts future mortality improvements in China, by geographical regions, as well as by causes of death. Deaths and population exposures data provided by the Chinese Center for Disease Control and Prevention was used for the period 2004–2019.

Description: LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA), and TAI have collaborated on an ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public. The Individual Life COVID-19 Project Work Group (Work Group) was formed as a collaboration of LIMRA, RGA, the SOA, and TAI to design, implement, and create the study and to produce and distribute a variety of analyses. This report is the fifth public release from this collaboration and contains the results of a cause of death analysis focused on how the rates of death for various causes were impacted throughout the pandemic period through the first quarter of 2021.

Description: A literature review was performed on mortality improvement, socioeconomic differences in mortality and their links to specific causes of death, and methods for analysis. It highlighted the fact that socioeconomic status (e.g., income and education) is closely linked to differences in mortality and that the longevity gap between socioeconomic groups is growing over time. It also informed the selection of key variables and the need to view mortality improvement as a complex interaction between specific causes of death.

Description: This report summarizes the results of a 2022 survey examining mortality improvement practices of life and annuity companies in the U.S. and Canada.

Description: The Candidate Connect at the 2024 ValAct Meeting provides information, inspiration and networking opportunities to actuarial candidates pursuing their ASA.

Description: In this session, presenters will share the impacts of transition to IFRS 17 on equity and various KPIs across insurance companies (Life & P&C), as well as share some observations of what the IFRS 17 landscape looks like across different global regions. The session will conclude with lessons learned and expectations for emerging practices under IFRS 17 globally.

Description: This video from Ben Keslowitz explains the concept of reinsurance, which is a financial arrangement where insurance companies transfer portions of their risk portfolios to other parties, known as reinsurers. This helps insurers manage large or catastrophic claims and optimize their risk components. The video also covers different types of reinsurance, such as proportional liability reinsurance, non-proportional reinsurance, and quota share coinsurance, each serving different purposes in risk management. Additionally, it discusses the reasons insurers might choose to reinsure their business, including liability risk mitigation, investment risk transfer, and entering new markets.